Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase

Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase

Abstract Background Casticin, an isoflavone compound extracted from the herb Fructus Viticis, has demonstrated anti-inflammatory and anticancer activities and properties. The aim of this study was to investigate the effects and mechanisms of casticin in nasopharyngeal carcinoma (NPC) cells and to de...

Full description

Bibliographic Details
Main Authors: Jingxian Liu, Jinghong Yang, Yuhe Hou, Zhenwei Zhu, Jie He, Hao Zhao, Xidong Ye, Dengke Li, Zhaohui Wu, Zhongxi Huang, Bingtao Hao, Kaitai Yao
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Cancer Cell International
Subjects:
Casticin
Nasopharyngeal carcinoma
Target
PI3K/AKT pathway
Online Access:https://doi.org/10.1186/s12935-019-1069-6

Internet

https://doi.org/10.1186/s12935-019-1069-6

Similar Items